196 related articles for article (PubMed ID: 22089141)
1. HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
Zuo Q; Wu W; Li X; Zhao L; Chen W
Oncol Rep; 2012 Mar; 27(3):819-24. PubMed ID: 22089141
[TBL] [Abstract][Full Text] [Related]
2. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
Siow D; Wattenberg B
Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
[TBL] [Abstract][Full Text] [Related]
3. ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion.
Castro-Castro A; Janke C; Montagnac G; Paul-Gilloteaux P; Chavrier P
Eur J Cell Biol; 2012; 91(11-12):950-60. PubMed ID: 22902175
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
5. Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ.
Hou H; Chen W; Zhao L; Zuo Q; Zhang G; Zhang X; Wang H; Gong H; Li X; Wang M; Wang Y; Li X
J Clin Pathol; 2012 Dec; 65(12):1088-96. PubMed ID: 22944623
[TBL] [Abstract][Full Text] [Related]
6. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
Rey M; Irondelle M; Waharte F; Lizarraga F; Chavrier P
Eur J Cell Biol; 2011; 90(2-3):128-35. PubMed ID: 20970878
[TBL] [Abstract][Full Text] [Related]
7. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of cortactin and HDAC6 in human prostatic foamy gland carcinoma.
Hou H; Zhao L; Chen W; Li J; Zuo Q; Zhang G; Zhang X; Li X
Int J Exp Pathol; 2015 Aug; 96(4):248-54. PubMed ID: 26112958
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.
Kanno K; Kanno S; Nitta H; Uesugi N; Sugai T; Masuda T; Wakabayashi G; Maesawa C
Oncol Rep; 2012 Sep; 28(3):867-73. PubMed ID: 22766642
[TBL] [Abstract][Full Text] [Related]
10. Cortactin deacetylation by HDAC6 and SIRT2 regulates neuronal migration and dendrite morphogenesis during cerebral cortex development.
Kim JY; Hwang HG; Lee JY; Kim M; Kim JY
Mol Brain; 2020 Jul; 13(1):105. PubMed ID: 32711564
[TBL] [Abstract][Full Text] [Related]
11. Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells.
Tsunoda K; Oikawa H; Tada H; Tatemichi Y; Muraoka S; Miura S; Shibazaki M; Maeda F; Takahashi K; Akasaka T; Masuda T; Maesawa C
J Invest Dermatol; 2011 Aug; 131(8):1710-9. PubMed ID: 21562571
[TBL] [Abstract][Full Text] [Related]
12. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions.
Valenzuela-Fernández A; Cabrero JR; Serrador JM; Sánchez-Madrid F
Trends Cell Biol; 2008 Jun; 18(6):291-7. PubMed ID: 18472263
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.
Namdar M; Perez G; Ngo L; Marks PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20003-8. PubMed ID: 21037108
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.
Husain M; Cheung CY
J Virol; 2014 Oct; 88(19):11229-39. PubMed ID: 25031336
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest.
Li GC; Zhang X; Pan TJ; Chen Z; Ye ZQ
Int J Urol; 2006 May; 13(5):581-6. PubMed ID: 16771729
[TBL] [Abstract][Full Text] [Related]
16. Cortactin affects cell migration by regulating intercellular adhesion and cell spreading.
van Rossum AG; Moolenaar WH; Schuuring E
Exp Cell Res; 2006 May; 312(9):1658-70. PubMed ID: 16527272
[TBL] [Abstract][Full Text] [Related]
17. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion.
Ding Y; Wang G; Ling MT; Wong YC; Li X; Na Y; Zhang X; Chua CW; Wang X; Xin D
Int J Oncol; 2006 Apr; 28(4):847-54. PubMed ID: 16525633
[TBL] [Abstract][Full Text] [Related]
18. Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.
Rosik L; Niegisch G; Fischer U; Jung M; Schulz WA; Hoffmann MJ
Cancer Biol Ther; 2014 Jun; 15(6):742-57. PubMed ID: 24618845
[TBL] [Abstract][Full Text] [Related]
19. HDAC6 modulates cell motility by altering the acetylation level of cortactin.
Zhang X; Yuan Z; Zhang Y; Yong S; Salas-Burgos A; Koomen J; Olashaw N; Parsons JT; Yang XJ; Dent SR; Yao TP; Lane WS; Seto E
Mol Cell; 2007 Jul; 27(2):197-213. PubMed ID: 17643370
[TBL] [Abstract][Full Text] [Related]
20. Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.
Tokui N; Yoneyama MS; Hatakeyama S; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Nakamura T; Ohyama C; Tsuboi S
Mol Med Rep; 2014 Apr; 9(4):1142-6. PubMed ID: 24549769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
